IP Library Granted Patent US 10,619,132
Granted Patent B2
US 10,619,132 · App. 15/595,560 · Granted Apr 14, 2020

Tissue-engineered constructs

Inventors: Shannon L. M. Dahl (Durham, NC); Laura E. Niklason (Greenwich, CT); Justin T. Strader (Cary, NC); William E. Tente (Seekonk, MA); Joseph J. Lundquist (Durham, NC)
Assignee: Humacyte, Inc.
C12N5/0068A61F2/04A61F2/06A61L27/16A61L27/18A61L27/34A61L27/3633A61L27/38A61L27/3895A61L27/54A61L27/58B29C53/005B29C53/36A61F2002/047A61F2002/048B29K2067/043B29K2105/256B29K2995/006B29K2995/0056B29L2023/00B29L2031/7532C12N2533/30C12N2533/40Y10T156/1038
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,619,132
App. No.
15/595,560
Granted
Apr 14, 2020
Kind
B2
Abstract

The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.

Claims (17)

1. A tubular scaffold comprising tubular biodegradable non-woven polyglycolic acid wherein the density of the polyglycolic acid is 45 mg/cc to 75 mg/cc and said density is uniform across the entire tubular scaffold, wherein the thickness of the polyglycolic acid is 0.8 to 1.2 mm and wherein the scaffold comprises polyglycolic acid fibers and the thickness of the fibers within the polyglycolic acid is 5 to 20 μm, and wherein the scaffold is substantially free of heavy metal contaminants, wherein the tubular scaffold is an ex vivo cell culture tubular scaffold.

2. The scaffold of claim 1 , wherein the length of the scaffold is 1 cm to 100 cm.

3. The scaffold of claim 1 , wherein the length of the scaffold is 10 cm to 40 cm.

4. The scaffold of claim 1 , wherein the inner diameter of the scaffold is 3 mm to 6 mm.

5. The scaffold of claim 1 , wherein the scaffold comprises trace amounts of heavy metal contaminants selected from the group consisting of: aluminum, barium, calcium, iodine, lanthanum, magnesium, nickel, potassium and zinc.

6. The scaffold of claim 1 , wherein the scaffold comprises non-biodegradable supports at each end.

7. A composition comprising

(a) a tubular scaffold comprising biodegradable non-woven polyglycolic acid, wherein the density of the polyglycolic acid is 45 mg/cc to 75 mg/cc and said density is uniform across the entire tubular scaffold, wherein the thickness of the polyglycolic acid is 0.8 to 1.2 mm and wherein the scaffold comprises polyglycolic acid fibers and the thickness of the fibers within the polyglycolic acid is 5 to 20 μm, wherein the tubular scaffold is an ex vivo cell culture tubular scaffold, and wherein the scaffold is substantially free of heavy metal contaminants;

(b) human cells seeded on the scaffold, and

(c) cell culture medium.

8. The composition of claim 7 wherein the cell culture medium comprises human serum.

9. The composition of claim 7 wherein the human cells comprise smooth muscle cells.

10. The composition of claim 7 wherein the human cells seeded on the scaffold are passaged less than 10 times when seeded.

11. The composition of claim 7 , wherein the length of the scaffold is 1 cm to 100 cm.

12. The composition of claim 7 , wherein the length of the scaffold is 10 cm to 40 cm.

13. The composition of claim 7 , wherein the inner diameter of the scaffold is 3 mm to 6 mm.

14. The composition of claim 7 , wherein the scaffold comprises non-biodegradable supports at each end.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Dec 16, 2025
From: HOOK SA LLC, AS PURCHASER AGENT
To: HUMACYTE GLOBAL, INC.
Reel/Frame 073234/0064 →
SECURITY INTEREST Recorded Dec 15, 2025
From: HUMACYTE, INC.; HUMACYTE GLOBAL, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P., AS AGENT
Reel/Frame 073214/0250 →
CHANGE OF NAME Recorded Feb 5, 2025
From: HUMACYTE, INC.
To: HUMACYTE GLOBAL, INC.
Reel/Frame 070121/0235 →
SECURITY INTEREST Recorded May 15, 2023
From: HUMACYTE GLOBAL, INC.
To: HOOK SA LLC, AS PURCHASER AGENT
Reel/Frame 063638/0933 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2021
From: BLUM, JULIANA; PRICHARD, HEATHER L.
To: HUMACYTE, INC.
Reel/Frame 057381/0951 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2017
From: DAHL, SHANNON L.M.; NIKLASON, LAURA E.; STRADER, JUSTIN T.; TENTE, WILLIAM E.; LUNDQUIST, JOSEPH J.
To: HUMACYTE, INC.
Reel/Frame 042439/0182 →
Continuity (5)
Continuation 14495310 · Sep 24, 2014
Continuation 14495339 · Sep 24, 2014
Continuation 13978422
Provisional Application 61430381 · Jan 6, 2011
Related Publication 20170306292A1 · Oct 26, 2017